SYNDAX PHARMACEUTICALS

Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor, in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor. Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.

#SimilarOrganizations #People #Financial #Event #Website #More

SYNDAX PHARMACEUTICALS

Social Links:

Twitter

Industry:

Biotechnology Clinical Trials Health Care Pharmaceutical

Founded:

2005-01-01

Address:

Waltham, Massachusetts, United States

Country:

United States

Website Url:

http://www.syndax.com

Total Employee:

51+

Status:

Active

Contact:

(185) 879-2799

Email Addresses:

[email protected]

Total Funding:

273.58 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins

Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

deciphera-pharmaceuticals-logo

Deciphera Pharmaceuticals

Deciphera Pharmaceuticals focuses on improving kinase inhibitor treatments.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

novabay-pharmaceuticals-logo

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

x4-pharmaceuticals-logo

X4 Pharmaceuticals

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.

Current Advisors List

dennis-podlesak_image

Dennis Podlesak Board Chairman @ Syndax Pharmaceuticals
Board_member

kim-p-kamdar_image

Kim P. Kamdar Member of the Board of Directors @ Syndax Pharmaceuticals
Board_member

artthur-m-pappas_image

Artthur M. Pappas Member of Board @ Syndax Pharmaceuticals
Board_member

pierre-legault_image

Pierre Legault Director @ Syndax Pharmaceuticals
Board_member

not_available_image

Keith A Katkin Director @ Syndax Pharmaceuticals
Board_member

michael-metzger_image

Michael Metzger Director @ Syndax Pharmaceuticals
Board_member

jennifer-jarrett_image

Jennifer Jarrett Director @ Syndax Pharmaceuticals
Board_member

william-meury_image

William Meury Director @ Syndax Pharmaceuticals
Board_member

Current Employees Featured

not_available_image

Peter Ordentlich
Peter Ordentlich Chief Scientific Officer @ Syndax Pharmaceuticals
Chief Scientific Officer
2013-11-01

keith-a-goldan_image

Keith A. Goldan
Keith A. Goldan Chief Financial Officer @ Syndax Pharmaceuticals
Chief Financial Officer
2022-06-01

daphne-karydas_image

Daphne Karydas
Daphne Karydas CFO @ Syndax Pharmaceuticals
CFO
2020-07-01

matthew-g-nerney_image

Matthew G. Nerney
Matthew G. Nerney CIO @ Syndax Pharmaceuticals
CIO
2017-10-01

kate-madigan_image

Kate Madigan
Kate Madigan CMO @ Syndax Pharmaceuticals
CMO
2022-03-01

briggs-morrison_image

Briggs Morrison
Briggs Morrison President, Head of Research & Development @ Syndax Pharmaceuticals
President, Head of Research & Development
2022-02-01

not_available_image

Luke Albrecht
Luke Albrecht General Counsel and Secretary @ Syndax Pharmaceuticals
General Counsel and Secretary
2016-08-01

michael-metzger_image

Michael Metzger
Michael Metzger CEO @ Syndax Pharmaceuticals
CEO
2022-01-01

suniket-fulzele_image

Suniket Fulzele
Suniket Fulzele Director, Pharmaceutical Development and Manufacturing @ Syndax Pharmaceuticals
Director, Pharmaceutical Development and Manufacturing
2020-07-01

Founder

not_available_image

Peter Ordentlich

Stock Details

Company's stock symbol is NASDAQ:SNDX

Investors List

herculescapital_image

Key Employee Changes

Date	New article
2022-06-13	Syndax Pharmaceuticals Announces Appointment of Keith A. Goldan as Chief Financial Officer
2022-03-01	Syndax Pharmaceuticals Announces Appointment of Kate Madigan, M.D., as Chief Medical Officer
2022-02-03	Syndax Pharmaceuticals Announces Transition of Michael A. Metzger to Chief Executive Officer; Briggs W. Morrison, M.D., to Assume Role of President, Head of Research & Development
2020-07-07	Syndax Pharmaceuticals Appoints Daphne Karydas as Chief Financial Officer

Official Site Inspections

http://www.syndax.com Semrush global rank: 2.91 M Semrush visits lastest month: 5.6 K

Host Informations
Whois Informations

Unable to get host informations!!!

Loading ...

America

Europe

Asia

Others

SYNDAX PHARMACEUTICALS

SYNDAX PHARMACEUTICALS

Social Links:

Industry:

Founded:

Address:

Country:

Website Url:

Total Employee:

Status:

Contact:

Email Addresses:

Total Funding:

Technology used in webpage:

Similar Organizations

Current Advisors List

Current Employees Featured

Founder

Stock Details

Investors List

Key Employee Changes

Official Site Inspections

More informations about "Syndax Pharmaceuticals" on Search Engine